Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/7/2018
SIETES contiene 92427 citas

 
 
<< anterior 21 a 40 de 743 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Russo EB. Cannabidiol claims and misconceptions. Trends Pharmacol Sci 2017;38:198-201. [Ref.ID 101988]
23.Tiene citas relacionadas Cita con resumen
Berkovic SF. Cannabinoids for epilepsy — Real data, at last. N Engl J Med 2017;376:2075-6. [Ref.ID 101596]
24.Tiene citas relacionadas Cita con resumen
Devinsky O, Cross JH, Laux L, Marsh E, Nabbout R, Scheffer IE, Thiele EA, Wright S, for the Cannabidiol in Dravet Syndrome Study Group. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med 2017;376:2011-20. [Ref.ID 101595]
25. Cita con resumen
Bradford AC, Bradford WD. Medical marijuana laws may be associated with a decline in the number of prescriptions for Medicaid enrollees. Health Affairs 2017;36:1 de mayo. [Ref.ID 101570]
26.Tiene citas relacionadas Cita con resumen
Livingston MD, Barnett TE, Delcher C, Wagenaar AC. Recreational cannabis legalization and opioid-related deaths in Colorado, 2000-2015. Am J Public Health 2017;107:1827-9. [Ref.ID 101388]
27. Cita con resumen
Anónimo. Brazil issues first license for sale of cannabis-based drug. DIA Daily 2017:1. [Ref.ID 101349]
28. Cita con resumen
Anónimo. Various states approve recreational, medical marijuana use. DIA Daily 2016:7. [Ref.ID 100907]
30. Cita con resumen
Anónimo. Administration to remove roadblock to marijuana research. DIA Daily 2016:1. [Ref.ID 100571]
31. Cita con resumen
Gulland A. Sixty seconds on . . . medical marijuana. BMJ 2016;354:i3962. [Ref.ID 100517]
32. Cita con resumen
Anónimo. Cannabis and cannabinoids. Med Lett Drugs Ther 2016;58:97-8. [Ref.ID 100510]
33. Cita con resumen
Rubin R. Senators urge expedited evaluation of medical use of cannabidiol. JAMA 2016;316:13 de julio. [Ref.ID 100491]
34. Cita con resumen
Bradford AC, Bradford D. Medical marijuana laws reduce prescription medication use In Medicare Part D. Health Affairs 2016;37:julio. [Ref.ID 100483]
36. Cita con resumen
Patel R, Wilson R, Jackson R, Ball M, Shetty H, Broadbent M, Stewart R, McGuire P, Bhattacharyya S. Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study . BMJ Open 2016;6:e009888. [Ref.ID 100279]
37. Cita con resumen
Gunn JKL, Rosales CB, Nuñez A, Gibson SJ, Christ C, Ehri JE. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open 2016;6:e009986. [Ref.ID 100112]
38. Cita con resumen
Kim HS, Hall KE, Genco EK, Van Dyke M, Monte AA. Marijuana tourism and emergency department visits in Colorado. N Engl J Med 2016;374:797-8. [Ref.ID 100070]
39.Tiene citas relacionadas Cita con resumen
Hall W, Lynskey M. Long-term marijuana use and cognitive impairment in middle age. JAMA Intern Med 2016;176:362-3. [Ref.ID 100010]
40.Tiene citas relacionadas Cita con resumen
Auer R, Vittinghoff E, Yaffe K, Kertesz SG, Levine DA, Albanese E, Whitmer RA, Jacobs Jr DR, Sidney S, Glymour MM, Pletcher MJ. Association between lifetime marijuana use and cognitive function in middle age: The Coronary Artery Risk Development in Young Adults (CARDIA) study. JAMA Intern Med 2016;176:352-61. [Ref.ID 100009]
Seleccionar todas
 
<< anterior 21 a 40 de 743 siguiente >>